PODDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

INSULET CORP

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026

$141.96+0.86 (+0.61%)

Close on Oct 19, 2026

Market cap: $9.85B
P/E (TTM): 26.5
Dividend yield: –

INSULET CORP cash flow statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31
Depreciation & Amortization	90	81	73	63	57	55	28	16	14	14	16	12	12	11	8.50	5.08	5.22
Stock-Based Compensation	63	69	48	41	34	36	29	38	32	24	19	23	13	9.92	7.73	5.06	4.20
Deferred Income Taxes	62	-137	0.50	-0.90	1.20	-1.30	-0.70	-0.40	-0.50	-0.20	-0.18	0	0.08	0.09	-11	–	–
Change in Accounts Receivable	–	–	-99	-13	-46	-14	-11	-15	-26	13	-9.79	-10	-4.51	-14	-3.62	-5.20	-6.97
Change in Inventory	-11	-32	-54	-49	-154	-51	-30	-39	1.70	-24	-0.72	-3.64	5.40	-3.03	1.88	-1.34	5.84
Change in Accounts Payable	49	2.20	-11	-2.40	-16	7.10	26	-5.40	–	–	–	–	–	–	–	–	–
Change in Unearned Revenue	–	–	–	–	–	–	–	–	1.06	-0.85	0.81	0.65	-4.55	2.86	-1.67	0.28	1.59
Operating Cash Flow	569	430	146	119	-68	84	98	36	41	16	-13	8.92	3.35	-29	-25	-36	-49
Capital Expenditures	-192	-125	-76	-123	-112	-129	-164	-157	-74	-22	-11	-11	-7.31	-11	-11	-6.55	-3.14
Acquisitions	–	0	-3.00	-26	0	0	–	–	0	0	-4.72	0	0	0	-38	–	–
Purchase of Investments	0	-12	-7.20	-7.80	0	-38	-151	-191	-298	-178	0	0	–	–	–	–	–
Sale & Maturity of Investments	–	–	0	0	40	218	248	169	164	16	0	0	–	–	–	–	–
Other Investing Activities	-3.20	0	-3.00	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Investing Cash Flow	-223	-146	-119	-191	-83	14	-74	-185	-211	-178	-15	-11	-7.31	-11	-49	-6.55	-3.14
Share Repurchases	-60	0	0	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Stock Issued	–	–	–	0	0	478	0	0	–	4.85	7.85	12	103	4.93	5.46	49	94
Debt Issued	–	–	–	–	–	–	780	0	392	334	0	194	0	–	–	–	–
Debt Repaid	–	–	–	–	–	–	–	–	–	–	–	-190	-2.00	0	-88	-33	-28
Taxes Paid on Share-Based Awards	-26	-7.60	-13	-17	-28	-30	-8.60	-18	-4.10	-2.87	-2.65	-8.67	-3.27	-1.54	-0.95	–	–
Other Financing Activities	0	0	-0.30	0	–	-2.20	0	0	–	–	–	–	–	–	–	-0.47	–
Financing Cash Flow	-595	-28	-14	-40	41	606	74	-8.70	305	177	-0.37	4.03	96	3.39	55	27	124
Foreign Exchange Rate Adjustments	12	-6.80	1.80	-4.30	-5.50	4.80	1.50	-1.40	0.40	0.03	-0.28	0	0	–	–	–	–
Net Change in Cash	-237	249	14	-117	-116	708	100	-159	135	15	-29	1.47	92	-37	-19	-15	71
Free Cash Flow	378	305	70	-3.90	-180	-45	-65	-122	-33	-6.20	-23	-2.57	-3.96	-40	-37	-42	-52
Income Taxes Paid	39	21	8.10	5.50	7.00	3.00	2.50	0.80	0.50	0.93	0.11	0.12	0.32	0.01	0.26	0.01	–
Interest Paid	51	47	50	34	22	2.60	0	0	2.50	3.69	4.03	4.66	5.70	6.20	5.17	8.09	6.82

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 71.1%
Operating margin: 16.9%
Net margin: 12.3%
Return on equity, FY2025: 18.1%

Financial strength

Current ratio: 2.48
Debt to equity: 0.67
Debt to assets: 30.0%
Cash to current liabilities: 71.9%

Valuation

P/E ratio: 26.5
Price to sales: 3.23
Price to book: 6.93
Dividend yield: –